•
Dec 31, 2021

Stryker Q4 2021 Earnings Report

Stryker's Q4 2021 results showed sales growth and earnings per share, but adjusted EPS decreased.

Key Takeaways

Stryker reported a 10.3% increase in net sales compared to 2020, reaching $4.7 billion. The reported EPS increased by 16.1% to $1.73, while adjusted EPS decreased by 3.6% to $2.71.

Reported net sales increased 10.3% from 2020 and 13.8% from 2019 to $4.7 billion.

Organic net sales increased 9.0% from 2020 and 6.2% from 2019.

Reported operating income margin was 17.4%.

Adjusted EPS decreased 3.6% to $2.71.

Total Revenue
$4.7B
Previous year: $4.26B
+10.3%
EPS
$2.71
Previous year: $2.81
-3.6%
Organic Net Sales Growth
9%
Previous year: -1.1%
-918.2%
Gross Profit
$3.05B
Previous year: $2.72B
+12.1%
Cash and Equivalents
$2.94B
Previous year: $2.94B
+0.0%
Free Cash Flow
$794M
Previous year: $1.07B
-25.9%
Total Assets
$34.6B
Previous year: $34.3B
+0.9%

Stryker

Stryker

Stryker Revenue by Geographic Location

Forward Guidance

Stryker expects 2022 organic net sales growth to be in the range of 6% to 8% and adjusted net earnings per diluted share to be in the range of $9.60 to $10.00.

Revenue & Expenses

Visualization of income flow from segment revenue to net income